Aspreva Pharmaceuticals' IPO

Aspreva Pharmaceuticals raised a round of funding on March 04, 2005. Investors include Public.

Aspreva identified, developed and commercialized new indications for approved drugs and late-stage drug candidates for patients living with uncommon diseases.…

Articles about Aspreva Pharmaceuticals' IPO: